<div id="readability-page-1"><p>BIT Capital GmbH lifted its stake in  Oscar Health, Inc. (NYSE:OSCR - Free Report) by 545.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,186,267 shares of the company's stock after purchasing an additional 5,227,152 shares during the quarter. Oscar Health comprises  3.3% of BIT Capital GmbH's portfolio, making the stock its 12th biggest holding. BIT Capital GmbH owned about 2.34% of Oscar Health worth $88,897,000 as of its most recent filing with the SEC.</p><ul><li>5 Small Cap Stocks With Explosive Upside Potential</li></ul><p>Several other hedge funds have also made changes to their positions in OSCR. Quarry LP increased its position in  Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after buying an additional 1,469 shares in the last quarter.  Jones Financial Companies Lllp increased its position in  Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after buying an additional 2,242 shares in the last quarter.  Strs Ohio acquired a new position in  Oscar Health during the 1st quarter valued at about $30,000.  Fifth Third Bancorp grew its stake in  Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock valued at $34,000 after purchasing an additional 1,413 shares during the last quarter.  Finally, Binnacle Investments Inc purchased a new stake in shares of  Oscar Health in the second quarter worth about $75,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Key Oscar Health News</h2><p>Here are the key news stories impacting Oscar Health this week:</p><ul>   <li><span>Positive Sentiment: </span>Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. <i></i><span>Zacks.com</span></li>   <li><span>Positive Sentiment: </span>Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>   <li><span>Neutral Sentiment: </span>A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. <i></i><span>Oscar Health Co-Founder Shifts to Advisory Leadership Role</span></li>   <li><span>Neutral Sentiment: </span>Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>   <li><span>Negative Sentiment: </span>Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li> </ul><h2>Oscar Health Stock Performance</h2><p>OSCR opened at $24.59 on Friday. The stock has a market cap of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.65 and a beta of 2.37. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock's 50 day simple moving average is $18.39 and its 200 day simple moving average is $16.06. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58. </p><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion for the quarter, compared to analysts' expectations of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 EPS. The company's revenue was up 52.6% compared to the same quarter last year.  As a group, equities analysts anticipate that  Oscar Health, Inc. will post 0.47 EPS for the current fiscal year. </p><h2>Analyst Ratings Changes</h2><p>OSCR has been the topic of a number of recent research reports. Raymond James Financial upgraded Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Weiss Ratings  reiterated a &#34;sell (d)&#34; rating on shares of Oscar Health in a research report on Tuesday, April 21st. Wells Fargo &amp; Company  set a $20.00 price target on Oscar Health and gave the company an &#34;equal weight&#34; rating in a report on Thursday. Wall Street Zen cut Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday. Finally, Zacks Research raised Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, May 7th. One research analyst  has rated the stock with a Strong Buy rating, two have assigned  a Buy rating, eight have given a Hold rating and one  has assigned  a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $20.22.</p><p><b>View Our Latest Report on OSCR</b></p><h2>Insider Activity at Oscar Health</h2><p>In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of Oscar Health stock in a transaction on Monday, April 6th. The shares were bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. This trade represents a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, Director Mario Schlosser sold 34,120 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $748,592.80. Following the transaction, the director directly owned 480,866 shares in the company, valued at approximately $10,550,200.04. This represents a 6.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock worth $4,283,140. Company insiders own  24.39% of the company's stock. </p><h2>About Oscar Health</h2> (Free Report)<p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.  </p><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Oscar Health</li><li>AI Server Earnings: Wall Street Sees One Clear Standout</li><li>Navitas: NVIDIA’s AI Power Broker?</li><li>A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below</li><li>NVIDIA's New Power Play: Why Fluence Is Surging</li></ul><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2><p>Before you consider Oscar Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OSCR

OSCG

OSCX

<p>BIT Capital GmbH increased its stake in Oscar Health by 545% in Q4, purchasing over 5.2 million shares. Other institutions like Quarry LP and Jones Financial also significantly boosted their positions. Meanwhile, Wells Fargo upgraded OSCR to 'hold' following an EPS beat, though revenue missed estimates. Analyst ratings vary, with Raymond James upgrading to 'outperform' while Weiss maintains a 'sell'.</p>

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

Fifth Third Bancorp

Wells Fargo

Raymond James Financial

Fifth Third Bancorp Pref Share FITBO 4.95 Perp 09/30/24 K

FIFTH THIRD BANK PREF SHARE FITB V6.625 P12/31/49 I

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

Fifth Third Bancorp Depositary Shs B Ser A Repr 1/40 6 % Perp Pfd Registered Shs B Ser A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

BIT Capital GmbH Purchases 5,227,152 Shares of Oscar Health, Inc. $OSCR